旅行距离与HPV相关癌症的总生存率在高负担状态中的关系
Sameer Vali Gopalani1, Hanh Dung Dao1, Lance Ford1
1Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.
Journal of registry management
|August 14, 2023
概括
与人类乳头瘤病毒 (HPV) 相关的癌症患者前往更远的治疗中心的患者的生存结果更差. 这凸显了旅行负担对癌症患者存活率的影响,以及对可访问护理的需求.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 专业癌症护理的地理可用性会影响患者的治疗结果.
- 人类乳头瘤病毒 (HPV) 相关的癌症是一个重大的公共卫生问题.
- 了解旅行距离在癌症生存中的作用对于医疗保健规划至关重要.
研究的目的:
- 调查在被诊断患有HPV相关癌症的患者中,到达学术卫生系统的旅行距离和整体存活率之间的关联.
- 量化不同旅行距离对患者生存率的影响.
主要方法:
- 利用了2005-2019年医院癌症登记数据.
- 使用网络分析计算单向旅行距离,从患者地址到学术医疗中心.
- 采用多变量Cox比例危险回归来分析生存数据,将距离分类为短距离 (<25英里),中间距离 (25-74.9英里) 和长距离 (≥75英里).
主要成果:
- 与短距离旅行相比,中长距离旅行的HPV相关癌症患者面临更高的死亡风险 (HR分别为1.23和1.15).
- 最低的调整后的5年生存率是在中距离组 (60.4%) 中观察到的,其次是远距离 (62.6%) 和短距离 (66.2%) 组.
结论:
- 到学术医疗中心的旅行距离与HPV相关癌症患者的整体存活率有显著的关联.
- 这些发现强调了解决旅行负担的重要性,这是改善HPV相关癌症患者治疗结果的关键因素.
- 减轻与旅行有关的障碍的策略可能会提高这种患者群体的存活率.
更多相关视频
相关概念视频
Cancer Survival Analysis
384
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
384
Comparing the Survival Analysis of Two or More Groups
223
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
223
Actuarial Approach
96
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
96
Hazard Ratio
158
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
158
Criteria for Causality: Bradford Hill Criteria - II
366
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
366
Assumptions of Survival Analysis
155
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
155


